Pfizer and BioNTech SE to Get $1.95 Billion from U.S. Government for Covid-19 Vaccine Production
Pfizer Inc and German biotech firm BioNTech SE will get US$1.95 billion from the US government to produce and deliver 100 million doses of their Covid-19 vaccine candidate, the companies said on Wednesday. The agreement allows the US government to acquire an additional 500 million doses, the Department of Health and Human Services and the Department of Defense said. The Trump administration has agreed to spend billions of dollars for the development and procurement of a potential vaccine.